Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: INNOVATION PATHWAYS, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-01 to 2025-06-30
Current total value of award: $2999780
Description: THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE